BioCentury | Nov 4, 2016
Strategy

The next (re)generation

...II study did not justify continuation. The company announced plans to merge with robotics company Microbot Medical...
...Cure Blindness, London, U.K. Macrocure Ltd. (NASDAQ:MCUR), Petah Tikva, Israel Massachusetts General Hospital, Boston, Mass. Microbot Medical...
Items per page:
1 - 1 of 1
BioCentury | Nov 4, 2016
Strategy

The next (re)generation

...II study did not justify continuation. The company announced plans to merge with robotics company Microbot Medical...
...Cure Blindness, London, U.K. Macrocure Ltd. (NASDAQ:MCUR), Petah Tikva, Israel Massachusetts General Hospital, Boston, Mass. Microbot Medical...
Items per page:
1 - 1 of 1